Long-term outcome of interferon-α-induced autoimmune thyroid disorders in chronic hepatitis C
✍ Scribed by Fumina Doi; Satoru Kakizaki; Hitoshi Takagi; Masami Murakami; Naondo Sohara; Toshiyuki Otsuka; Takehiko Abe; Masatomo Mori
- Book ID
- 111237361
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 109 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0106-9543
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Clinical relevance of occult hepatitis C virus (HCV) and/or hepatitis B virus (HBV) infection(s) remains uncertain years after interferon (IFN) therapy for chronic hepatitis C. By 1993, 38 sustained virological responders (SVRs) showing HCV RNA clearance at 6 months post‐treatment and 3
We reanalyzed the results of a pilot study of recombinant alpha-interferon therapy for chronic non-A, non-B hepatitis in light of the recent discovery of the hepatitis C virus and the development of diagnostic assays for this agent. Stored serum samples from 10 patients treated between 1984 and 1986